The complex of Grb2-SH2 a BCR-Abl target peptide reveals that the peptide binds in a β-turn conformation; Trp 121 closes the binding site C-terminal to the phosphotyrosyl residue of the ligand and prevents it from assuming the expected extended conformation.
References
Lowenstein, E.J. et al. Cell 70, 431–442 (1992).
Matuoka, K., Shibata, M., Yamakawa, A. & Takenawa, T. Proc. Nat. Acad. Sci. USA 89, 9015–9019 (1992).
Buday, L. and Downward, J. Cell 73, 611–620 (1993).
Chardin, P. et al. Science 260, 1338–1343 (1993).
Egan, S.E. et al. Nature 363, 45–51 (1993).
Li, N. et al. Nature 363, 85–88 (1993).
Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T. & Bowtell, D. Nature 363, 83–85 (1993).
Cadena, D.L. & Gill, G.N. FASEB J. 6, 2332–2338 (1992).
Cantley, L.C. et al. Cell 64, 281–302 (1991).
Songyang, Z. et al. Cell 72, 767–778 (1993).
Batzer, A.G., Rotin, D., Ureqa, J.M., Skolnik, R.Y. & J. Mol. Cell Biol 14, 5192–5201 (1994).
Simon, M.A., Bowtell, D.D.L., Dodson, G.S., Laverty, T.R. & Rubin, G.M. Cell 67, 701–716 (1991).
Gishizky, M.L. Ann. Rep. Med. Chem. Chapt. 26, 247–253 (1995).
Waksman, G. et al. Nature 358, 646–653 (1992).
Waksman, G., Schoelson, S.E., Pant, N., Cowburn, D. & Kuriyan, J. Cell 72, 779–790 (1993).
Gilmer, T. et al. J. Biol. Chem. 269, 31711–31719 (1994).
Xu, R.X. et al. Biochemistry 34, 2107–2121 (1995).
Overduin, M., Rios, C.B., Mayer, B.J., Baltimore, D. & Cowburn, D. Cell 70, 697–704 (1992).
Overduin, M., Mayer, B., Rios, C.B., Baltimore, D. & Cowburn, D. Proc. Nat. Acad. Sci. USA 89, 11673–11677 (1992).
Booker, G.W. et al. Nature 358, 684–687 (1992).
Eck, M.J., Schoelson, S.E. & Harrison, S.C. Nature 362, 87–91 (1993).
Eck, M.J., Atwell, S.K., Schoelson, S.E. & Harrison, S.C. Nature 368, 764–769 (1994)
Mikol, V., Bauman, G., Keller, T.H., Manning, U. & Zurini, M.N.G. J. Mol. Biol. 246, 344–355 (1995).
Lee, C.-H. et al. Structure 2, 423–438 (1994).
Pascal, S.M. et al. Cell 77, 461–472 (1994).
Zhou, M.-M. et al. Proc. Nat. Acad. Sci. USA 92, 7784–7788 (1995).
Hatada, M.H. et al. Nature 377, 32–38 (1995).
Narula, S.S. et al. Structure 3, 1061–073 (1995).
Maignan, S. et al. Science 268, 291–293 (1995)
Chardin, P., Cussac, D., Maignan, S. & Ducruix, A. FEBS Letters 369, 47–51 (1995).
Pendergast, A.M. et al. Cell 75, 175–185 (1993).
Marengere, L.E.M. et al. Nature 369, 502–505 (1994).
Timm, D., Guruprasad, L., Bax, B. & Blundell, T. Euro. J. of Med. Chem. 30, 612s–614s (1994).
Kabsch, W. J. Appl. Crystallogr. 21, 916–924 (1988).
Collaborative Computing Project No. 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D50, 760–763 (1994).
Fitzgerald, P.M.D. J. Appl. Crystallogr., 21, 273–278 (1988).
Brünger, A.T. X-PLOR Version 3.1 A system for X-ray Crystallography and NMR, Yale University Press. New Haven and London (1992).
Jones, T.A., Zou, J.-Y., Cowan, S.W. & Kjelgaard, M. Acta Crystallogr. D47, 110–119 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rahuel, J., Gay, B., Erdmann, D. et al. Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode. Nat Struct Mol Biol 3, 586–589 (1996). https://doi.org/10.1038/nsb0796-586
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nsb0796-586
- Springer Nature America, Inc.
This article is cited by
-
GRB2 dimerization mediated by SH2 domain-swapping is critical for T cell signaling and cytokine production
Scientific Reports (2023)
-
Comparing pharmacophore models derived from crystallography and NMR ensembles
Journal of Computer-Aided Molecular Design (2017)
-
Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor
Journal of Biomolecular NMR (2008)
-
Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation
BMC Structural Biology (2007)